The stem cell agency board should be restructured to shore up the integrity of its grant process… Read more…
“Grifting” the CIRM from Cleveland … Read more…
Another view of STEM reaping stem cell funds despite panel’s advice Read more…
Q&A about Geron’s decision and its implications for the stem cell field Read more…
Grant to pursue preclinical development of HuCNS-SC Cells for Alzheimer’s disease Read more…
The governing board of the California Institute for Regenerative Medicine (CIRM) approved a $30M initiative Read more…
Jonathan Thomas, PhD, JD, will be the new Chairman of the California Institute for Regenerative Medicine, Read more…
Jonathan Thomas, a founding partner of Saybrook Capital, has been nominated to lead CIRM, Read more…
The collapse of efforts to resolve California’s financial crisis places the $3B stem cell research program perilously close to a serious cash crunch. Read more…
A research team at the Cedars-Sinai Regenerative Medicine Institute has been awarded a $1.9M grant Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.